Champions Oncology (CSBR) Accounts Payables (2011 - 2026)

Champions Oncology (CSBR) has 16 years of Accounts Payables data on file, last reported at $5.6 million in Q3 2026.

• On a quarterly basis, Accounts Payables rose 16.24% year-over-year to $5.6 million in Q3 2026; TTM through Jul 2026 was $5.6 million, a 16.24% increase from a year earlier, with the FY2026 full-year figure at $6.9 million, up 62.5% from the prior year.
• Accounts Payables for Q3 2026 stood at $5.6 million, down from $6.9 million in the prior quarter.
• Across five years, Accounts Payables topped out at $6.9 million in Q2 2026 and bottomed at $2.5 million in Q3 2022.
• Historically, Accounts Payables has averaged $4.9 million across 5 years, with a median of $4.9 million in 2024.
• The widest annual swing landed in 2023, when Accounts Payables jumped 127.0%; it then fell 26.76% in 2025.
• Year by year, Accounts Payables stood at $4.6 million in 2022, then slipped by 1.5% to $4.5 million in 2023, then increased by 7.01% to $4.9 million in 2024, then climbed by 23.47% to $6.0 million in 2025, then declined by 6.02% to $5.6 million in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $5.6 million in Q3 2026, $6.9 million in Q2 2026, and $5.7 million in Q1 2026.